GLP-1 receptors – the drugs behind Ozempic and Mounjaro – could have great benefits for colon cancer patients, the study suggests


GLP-1 receptors – the drugs behind Ozempic and Mounjaro – could have great benefits for colon cancer patients, the study suggests